Pharmafile Logo

payer survey

- PMLiVE

Global healthcare consultancy Uptake Strategies unveils a newly refreshed identity

Uptake, formerly known as Uptake Strategies, has revealed a bold brand refresh for its 18th year

- PMLiVE

AstraZeneca presents positive phase 3 results for Imfinzi regimen in lung cancer

Around 2.2 million people are diagnosed with lung cancer globally each year

- PMLiVE

Gilead’s COVID-19 treatment shows promising results in vulnerable patient populations

Veklury demonstrated a reduction in mortality and hospital readmission rates

- PMLiVE

Roche reports positive phase 3 data for Tecentriq combination in liver cancer

More than 900,000 people are diagnosed with the disease globally each year

- PMLiVE

Shionogi’s cefiderocol shows efficacy against difficult-to-treat bacterial infections

Antimicrobial resistance has been declared as one of the top ten threats to global health

- PMLiVE

How to deal with HCPs’ change in preferences after the pandemic

By Darren Talbot (pictured right) and Dirk Szynka (pictured left)

- PMLiVE

Merck to acquire Prometheus Biosciences for almost $11bn

The deal includes the biotech’s lead candidate for ulcerative colitis and Crohn's disease

- PMLiVE

Moderna/Merck’s cancer vaccine shows promise in high-risk melanoma patients

Nearly 325,000 new cases of melanoma were diagnosed globally in 2020

- PMLiVE

New beginnings – learning the language of change

Behaviour change is a catalyst for improved performance and greater capabilities to face major healthcare challenges

- PMLiVE

New report reveals ‘major’ financial burdens faced by atopic dermatitis patients

The report, commissioned by Sanofi, analyses the economic impact of the condition

Launch in the UK with CHASE Testimonials

Launch your UK medicines or medical technology with CHASE. Click here: https://bit.ly/3GupSOI

CHASE

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links